Published
Neal S. Kleiman, MD, FACC, MSCAI chief of the section of interventional cardiology at Houston Methodist DeBakey Heart & Vascular Center, discusses transcatheter aortic valve replacement (TAVR) evaluation and treatment using JenaValve Trilogy (JVT) and J-Valve for patients with aortic regurgitation.
- Category
- Cardiology
Be the first to comment
Up Next
-
11:45
Aortic Regurgitation: What Should Patients Know?
-
15:36
Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40-75 Years | JACC
-
10:29
Echocardiographic Assessment of: AORTIC REGURGITATION (Part 3)
-
04:24
Understanding Blood Pressure and Hypertension | Houston Methodist
-
09:38
Aortic Regurgitation
-
05:59
For Patients: Thoracic Aortic Pathologies Involving the Aortic Arch
-
11:51
Echocardiographic Assessment of: AORTIC REGURGITATION (Part 4)
-
06:48
"Aortic valve fenestrations: An unrecognized cause of severe regurgitation"
-
05:19
Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
-
08:54
Houston oncologist discusses groundbreaking treatment in cancer medicine
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
